Data as of May 24
| -0.12 / -0.88%|
The 6 analysts offering 12-month price forecasts for BioScrip Inc have a median target of 16.00, with a high estimate of 17.00 and a low estimate of 13.00. The median estimate represents a +18.69% increase from the last price of 13.48.
The current consensus among 6 polled investment analysts is to Buy stock in BioScrip Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.